ecrin-mdr-crcClinical2017Colorectale kankerColorectal cancerColorectal CancerColorectale KankerInterventionalhttps://newmdr.ecrin.org/Study/2536570Belgium5CELEBREX 200 mg harde capsulesECRIN MDRCompletedfalseThe influence of the human body on the fate of Celebrex for the prevention/treatment of colorectal cancer: plasma concentration and elimination of Celebrex in healthy volunteersPrimary objectives: To study the pharmacokinetics of Celecoxib for the prevention/treatment of colorectal cancer Primary endpoints: The pharmacokinetic profiling of Celecoxib following oral administration in healthy volunteers2017-05-1525365702017-000131-13